INTELLIA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.21 USD | -6.56% |
|
-10.04% | -24.14% |
| May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
| May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart calendar Intellia Therapeutics, Inc.
f659cde.RoIps5steC-3ZjIKnzRVbWmwge154a6oJWFc8q50KVU.Gcpe49Z5GVrCVwVV63kPL1qDxaEpoMzkSDVvp_gzUwUF4Vj9rF0NatsUZw~1cb7cfa5ba243ab9e2f30ff5d339651c
Upcoming events on Intellia Therapeutics, Inc.
Past events on Intellia Therapeutics, Inc.
| 2024-05-13 | BofA Securities Health Care Conference |
| 2024-05-13 | RBC Capital Markets Global Healthcare Conference |
| 2024-05-09 08:00 am | Q1 2024 Earnings Call |
| 2024-05-09 07:30 am | Q1 2024 Earnings Release |
| 2024-03-13 03:05 pm | Barclays Global Healthcare Conference |
| 2024-03-12 01:00 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-03 | TD Cowen Health Care Conference |
| 2024-02-22 08:00 am | Q4 2023 Earnings Call |
| 2024-02-22 07:30 am | Q4 2023 Earnings Release |
| 2024-01-09 08:15 pm | JPMorgan Healthcare Conference |
| 2023-11-15 03:00 am | Jefferies London Healthcare Conference |
| 2023-11-09 08:00 am | Q3 2023 Earnings Call |
| 2023-11-09 07:30 am | Q3 2023 Earnings Release |
| 2023-11-02 06:30 am | International ATTR Amyloidosis Meeting |
| 2023-10-09 | Cell & Gene Meeting on the Mesa Conference |
| 2023-09-26 | Cantor Global Healthcare Conference |
| 2023-09-25 | BMO Gene Editing Conference |
| 2023-09-06 10:15 am | Wells Fargo Healthcare Conference |
| 2023-08-03 08:00 am | Q2 2023 Earnings Call |
| 2023-08-03 07:30 am | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 43,1 42,1 2.39% | 58,0 66,8 -13.13% | 33,1 29,2 13.37% | 52,1 50,0 4.21% | 36,3 50,0 -27.51% | 68,5 |
|
EBITDA Million USD | Released Forecast Spread | -101 -105 3.93% | -130 -134 2.56% | -261 -259 -0.86% | -451 -434 -3.94% | -506 -482 -5% | -479 |
|
EBIT Million USD | Released Forecast Spread | -106 -106 -0.58% | -137 -131 -4.35% | -268 -261 -2.66% | -458 -450 -1.8% | -515 -511 -0.9% | -508 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -99,5 -99,0 -0.49% | -134 -126 -6.56% | -268 -259 -3.57% | -474 -465 -1.97% | -481 -478 -0.72% | -499 |
|
Net income Million USD | Released Forecast Spread | -99,5 -99,0 -0.49% | -134 -126 -6.56% | -268 -254 -5.62% | -474 -463 -2.33% | -481 -475 -1.24% | -490 |
|
EPS USD | Released Forecast Spread | -2,11 -2,10 -0.66% | -2,40 -2,27 -5.73% | -3,78 -3,63 -4.01% | -6,16 -6,13 -0.52% | -5,42 -5,40 -0.44% | -5,15 |
| Announcement Date | 27/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11,3 8,57 31.31% | 14,0 9,50 47.7% | 13,3 10,9 21.37% | 13,6 10,7 26.72% | 12,6 11,1 13.35% | 13,6 11,3 20.14% | 12,0 12,0 0.32% | -1,92 11,4 -116.88% | 28,9 9,07 219.19% | 18,5 | 10,6 | 10,8 | 14,7 | 19,7 |
|
EBITDA Million USD | Released Forecast Spread | -104 -76,2 -35.93% | -108 -102 -6.33% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -144 -83,7 -72.41% | -98,3 -94,8 -3.71% | -106 -105 -0.5% | -110 -110 0.04% | -112 -118 5.13% | -132 -120 -10.21% | -131 -139 5.42% | -140 -137 -2.47% | -114 -135 15.4% | -128 | -140 | -143 | -145 | -147 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -147 -85,0 -72.82% | -101 -93,6 -7.56% | -113 -105 -8.16% | -113 -110 -3.43% | -103 -116 11.31% | -124 -115 -7.76% | -122 -134 8.73% | -132 -132 0.07% | -107 -127 15.54% | -123 | -134 | -138 | -140 | -142 |
|
Net income Million USD | Released Forecast Spread | -147 -83,2 -76.58% | -101 -92,6 -8.77% | -113 -105 -8.16% | -113 -109 -4.41% | -103 -115 10.57% | -124 -115 -7.38% | -122 -133 8.15% | -132 -130 -1.91% | -107 -125 14.24% | -120 | -131 | -134 | -140 | -142 |
|
EPS USD | Released Forecast Spread | -1,96 -1,10 -77.8% | -1,33 -1,31 -1.7% | -1,49 -1,25 -19.52% | -1,38 -1,36 -1.33% | -1,17 -1,37 14.79% | -1,40 -1,31 -7.12% | -1,38 -1,50 8.12% | -1,46 -1,43 -1.82% | -1,12 -1,37 18.31% | -1,22 | -1,34 | -1,36 | -1,33 | -1,27 |
| Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 09/11/23 | 22/02/24 | 09/05/24 | - | - | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Intellia Therapeutics, Inc.
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NTLA Stock
- Calendar Intellia Therapeutics, Inc.
